Significance of AgNORs and Ki-67 Proliferative Markers in Differential Diagnosis of Thyroid Lesions
Tóm tắt
We aimed to assess the utility of quantitative analysis of AgNORs and Ki67 labeling index (LI) in the differential diagnosis of different thyroid lesions. This study included: 25 papillary carcinomas, 7 follicular carcinomas, 21 follicular adenomas and 27 nodular goiters. Using a semiautomatic image analysis system, Ag NORs parameters were measured and calculated including: total area of AgNORs, mean Ag NOR number in nuclei, nuclear area, mean area of AgNOR dots per each nucleus, number of central and marginal AgNOR dots, and the relative ratio of total area of AgNOR dots/total area of nucleus. Ki67 immunostaining was performed and the LI was determined. There was a significant difference between groups of thyroid lesions regarding total area of AgNORs, Ag NOR number and number of marginal Ag NOR dots. According to receiver operating characteristic curve, Ag NORs number =2.91 and marginal Ag NORs = 2.67 were useful cut off values above which follicular carcinoma can be diagnosed with 100 % sensitivity, 79 % specificity, 76 % PPV, 100 % NPV and 85 % diagnostic accuracy for both parameters. Mean Ki67 LI in our study was 14.12 ± 2.29, 61.42 ± 3.77, 34.90 ± 3.49 and 18.60 ± 1.96 for papillary carcinoma, follicular carcinoma, follicular adenoma and nodular goiter respectively. Ki67 LI showed statistically significant difference between follicular carcinoma and follicular adenoma (p = 0.026) and between papillary carcinoma and follicular adenoma (p = 0.007). Quantification of Ag NORs and Ki67 LI could be used as helpful ancillary methods in the differentiation between different thyroid lesions.
Tài liệu tham khảo
Baloch ZW, LiVolsi VA (2002) Follicular-patterned lesions of the thyroid: the bane of the pathologist. Am J Clin Pathol 117(1):143–150
Rosai J (2004) Thyroid gland. In: Rosai J (ed) Rosai and Ackerman’s surgical pathology, volume (2), Ch (9), 9th edn. Mosby, Edinburgh, pp 515–594
Mase T, Funahashi H, Koshikawa T, Imai T, Nara Y, Tanaka Y, Nakao A (2003) HBME-1 immunostaining in thyroid tumors especially in follicular neoplasm. Endocr J 50(2):173–177
Rezk S, Brynes RK, Nelson V, Thein M, Patwardhan N, Fischer A, Khan A (2004) beta-Catenin expression in thyroid follicular lesions: potential role in nuclear envelope changes in papillary carcinomas. Endocr Pathol 15(4):329–337
Aiad HA, Kandil MA, Asaad NY, El-Kased AM, El-Goday SF (2008) Galectin-3 immunostaining in cytological and histopathological diagnosis of thyroid lesions. J Egypt Natl Canc Inst 20(1):36–46
Rivera M, Ricarte-Filho J, Patel S, Tuttle M, Shaha A, Shah JP, Fagin JA, Ghossein RA (2010) Encapsulated thyroid tumors of follicular cell origin with high grade features (high mitotic rate/tumor necrosis): a clinicopathologic and molecular study. Hum Pathol 41(2):172–180
Volante M, Collini P, Nikiforov YE, Sakamoto A, Kakudo K, Katoh R, Lloyd RV, LiVolsi VA, Papotti M, Sobrinho-Simoes M, Bussolati G, Rosai J (2007) Poorly differentiated thyroid carcinoma: the Turin proposal for the use of uniform diagnostic criteria and an algorithmic diagnostic approach. Am J Surg Pathol 31(8):1256–1264
Sofiadis A, Tani E, Foukakis T, Kjellman P, Skoog L, Höög A, Wallin G, Zedenius J, Larsson C (2009) Diagnostic and prognostic potential of MIB-1 proliferation index in thyroid fine needle aspiration biopsy. Int J Oncol 35(2):369–374
Slowińska-Klencka D, Klencki M, Popowicz B, Sporny S, Lewiński A (2004) Multiparameter analysis of AgNOR in thyroid lesions: comparison with PCNA expression. Histol Histopathol 19(3):785–792
Mehrotra A, Goel MM, Singh K (2002) Ki-67 and AgNOR proliferative markers as diagnostic adjuncts to fine needle aspiration cytology of thyroid follicular lesions. Anal Quant Cytol Histol 24(4):205–211
Howell WM (1982) Selective staining of nucleolus organiser regions (NORs). In: Busch H, Rothblum L (eds) The cell nucleus. Vol IX. Academic, New York, pp 89–143
Ploton D, Menager M, Jeannesson P, Himber G, Pigeon F, Adnet JJ (1986) Improvement in the staining and in the visualization of the argyrophilic proteins of the nucleolar organizer region at the optical level. Histochem J 18(1):5–14
Bukhari MH, Niazi S, Khan SA, Hashmi I, Perveen S, Qureshi SS, Chaudhry NA, Qureshi GR, Hasan M (2007) Modified method of AgNOR staining for tissue and interpretation in histopathology. Int J Exp Pathol 88(1):47–53
Canet V, Montmasson MP, Usson Y, Giroud F, Brugal G (2001) Correlation between silver-stained nucleolar organizer region area and cell cycle time. Cytometry 43(2):110–116
Kanematsu E, Matsui H, Deguchi T, Yamamoto O, Korematsu M, Kobayashi A, Nezasa S, Yamamoto N, Takeuchi T, Tanaka T, Kawada Y (1997) Signifcance of AgNOR counts for distinguishing carcinoma from adenoma and hyperplasia in parathyroid gland. Hum Pathol 28(4):421–427
Augustynowicz A, Dziecioł J, Barwijuk-Machała M, Dadan J, Puchalski Z, Sulkowski S (2004) Assessment of proliferative activity of thyroid Hürthle cell tumors using PCNA, Ki-67 and AgNOR methods. Folia Histochem Cytobiol 42(3):165–168
Kummoona R, Jabbar A, Kareem Al-Rahal D (2008) Proliferative activity in oral carcinomas studied with Ag-NOR and electron microscopy. Ultrastruct Pathol 32(4):139–146
Gerdes J, Lemke H, Baisch H, Wacker HH, Schwab U, Stein H (1984) Cell cycle analysis of a cell proliferation associated human nuclear antigen defined by the monoclonal antibody Ki-67. J Immunol 133:1710–1715
Kjellman P, Zedenius J, Lundell G, Backdahl M, Farnebo LO, Hamberger B, Larsson C, Wallin G (2006) Predictors of outcome in patients with papillary thyroid carcinoma. Eur J Surg Oncol 32(3):345–352
Ito Y, Miyauchi A, Kakudo K, Hirokawa M, Kobayashi K, Miya A (2010) Prognostic significance of ki-67 labeling index in papillary thyroid carcinoma. World J Surg 34(12):3015–3021
Mar KC, Eimoto T, Nagaya S, Tateyama H (2006) Cell proliferation marker MCM2, but not Ki67, is helpful for distinguishing between minimally invasive follicular carcinoma and follicular adenoma of the thyroid. Histopathology 48:801–807
Mehrotra P, Gonzalez MA, Johnson SJ, Coleman N, Wilson JA, Davies BR, Lennard TW (2006) Mcm-2 and Ki-67 have limited potential in preoperative diagnosis of thyroid malignancy. Laryngoscope 116:1434–1438
Królicka A, Kobierzycki C, Puła B, Podhorska-Okołów M, Piotrowska A, Rzeszutko M, Rzeszutko W, Rabczyński J, Domosławski P, Wojtczak B, Dawiskiba J, Dzięgiel P (2010) Comparison of metallothionein (MT) and Ki-67 antigen expression in benign and malignant thyroid tumours. Anticancer Res 30(12):4945–4949
Heikkilä A, Siironen P, Hagström J, Heiskanen I, Sankila R, Louhimo J, Haglund C, Arola J (2010) Follicular thyroid neoplasm: clinicopathologic features suggesting malignancy. APMIS 118(11):846–854
Pujani M, Arora B, Pujani M, Singh SK, Tejwani N (2010) Role of Ki-67 as a proliferative marker in lesions of thyroid. Indian J Cancer 47(3):304–307
Delellis RA, Lloyd RV, Heitz PU, Eng C (eds) (2004) World Health Organization classification of tumors. Pathology and genetics of tumors of endocrine organs. IARC Press, Lyon
Aubele M, Biesterfeld S, Derenzini M, Hufnagl P, Martin H, Ofner D, Ploton D, Ruschoff J (1994) Guidelines of AgNOR quantitation. Zentralbl Pathol 140:107–108
Hufnagl P, Guski H, Schulz HJ (1994) Measuring of AgNORs using image analysis. Zentralbl Pathol 140(1):31–35
Słowińska-Klencka D, Klencki M, Popowicz B, Lewiński A (2003) AgNOR quantification in the diagnosis of follicular pattern thyroid lesions. Anal Quant Cytol Histol 25(6):347–352
Solymosi T, Toth V, Sapi Z, Bodo M, Gal I, Csanate L (1996) Diagnostic value of AgNORs method in thyroid cytopathology: correlation with morphometric measurements. Diagn Cytopathol 14:140–144
Asorta S, Sharma J (2008) Role of AgNors in thyroid lesions on fine needle aspiration cytology smears. J Cytol 25:18–22
Cornianu M, Milos L, Golu L, Taban S, Milos A (2006) Proliferative activity of thyroid hurthle cell tumors. Acta Endocrinologica (Buc) 3:269–282
Lewy-Trenda I, Janezukowics J, Wierzchniewska L (2006) Practical application of proliferation markers (MIB-I, PCNA, AgNOR) expression analysis of differential diagnostics of nodular thyroid lesions. Wiad Lek 59(1-2):32–37, abstract
Ciobanu D, Căruntu ID, Vulpoi C, Florea N, Giuşcă SE (2006) Morphometric parameters and silver stain used in diagnosis of thyroid follicular diseases. Rom J Morphol Embryol 47(4):323–330
Rüschoff J, Prasser C, Cortez T, Höhne HM, Hohenberger W, Hofstädter F (1993) Diagnostic value of AgNOR staining in follicular cell neoplasms of the thyroid: comparison of evaluation methods and nucleolar features. Am J Surg Pathol 17(12):1281–1288
Hepburn PJ, Glynne-Jones E, Goddard L, Gee JM, Harper ME (1995) Cell proliferation in prostatic carcinoma: comparative analysis of Ki-67, MIB-1 and PCNA. Histochem J 27(3):196–203
Ronckers C, Ron E (2006) Thyroid cancer. In, Freedman LS, Edwards BK, Ries LAG, Young JL (eds). Cancer Incidence in Four Member Countries (Cyprus, Egypt, Israel, and Jordan) of the Middle East Cancer Consortium (MECC) Compared with US SEER. National Cancer Institute. NIH Pub. No. 06-5873. Bethesda, MD, pp 121–130
Erickson LA, Jin L, Wollan PC, Thompson GB, van Heerden J, Lloyd RV (1998) Expression of p27/kip1 and Ki-67 in benign and malignant thyroid tumors. Mod Pathol 11(2):169–174
Erickson LA, Jin L, Goellner JR, Lohse C, Pankratz VS, Zukerberg LR, Thompson GB, van Heerden JA, Grant CS, Lloyd R (2000) Pathologic features, proliferative activity, and cyclin D1 expression in Hurthle cell neoplasms of the thyroid. Mod Pathol 13(2):186–192
Horii A, Yoshida J, Sakai M, Okamoto S, Honjo Y, Mitani K, Hattori K, Kubo T (1999) Ki-67 positive fractions in benign and malignant thyroid tumours: application of flow cytometry. Acta Otolaryngol 119(5):617–620
Rickert D, Mittermayer C, Lindenfelser R, Biesterfeld S (2000) MIB-1 immunohistometry of follicular adenoma and follicular carcinoma of the thyroid gland. Anal Quant Cytol Histol 22(3):229–234
Erickson LA, Yousef OM, Jin L, Lohse CM, Pankratz VS, Lloyd RV (2000) p27kip1 expression distinguishes papillary hyperplasia in Graves’ disease from papillary thyroid carcinoma. Mod Pathol 13(9):1014–1019
Zidan J, Karen D, Stein M, Rosenblatt E, Basher W, Kuten A (2003) Pure versus follicular variant of papillary thyroid carcinoma: clinical features, prognostic factors, treatment and survival. Cancer 97(5):1181–1185